@article {2300, title = {Comparative Study of Paracetamol vs Paracetamol Plus Acupressure for Pain Relief in Diabetic Neuropathy Patients}, journal = {Pharmacognosy Journal}, volume = {16}, year = {2024}, month = {June 2024}, pages = {602-605}, type = {Research Article}, chapter = {602}, abstract = {

Background: Diabetes Mellitus (DM) is a chronic metabolic disorder that causes neuropathy. Diabetic neuropathy causes severe pain and needs therapy to relieve its pain. In Indonesia, the therapy uses paracetamol, sometimes combined with acupressure. However, the efficacy of the combination therapy needs to be better understood. Purpose: This study aimed to elucidate the efficacy of paracetamol vs paracetamol combined with acupressure for pain relief in diabetic neuropathy patients. Materials and methods: This study used a cross-sectional study design. Total of 70 participants were agreed to involved in this study. The patients were then interviewed, and their visual analogue scale was assessed. The data was then analysed statistically using Pearson{\textquoteright}s correlation. Result: Out of the 70 patients diagnosed with type II DM, 40 had Diabetic Neuropathic Pain (DNP). Shockingly, most of the patients with type II DM and DNP were females, accounting for 33 out of 40 cases (82.50\%). The study found a significant correlation between the type of therapy and the decrease in VAS scores for diabetic patients with neuropathic pain (p<=0.05). Patients treated with paracetamol and acupressure showed more improvement in the VAS score than those treated with only paracetamol. Conclusion: The study suggests that the combination treatment could benefit DNP as an analgesic for type II DM patients. Advanced study is required to be performed using larger samples so that accurate data can be obtained.

}, keywords = {Acupressure, Diabetic neuropathic pain, Paracetamol, Type II diabetes mellitus, Visual analogue scale}, doi = {10.5530/pj.2024.16.94}, author = {I Made Subhawa Harsa and Andiani and Sulistiawati and Lilik Herawati and Hanik Badriyah Hidayati and Kuntaman} } @article {2418, title = {SCN9A and SCN10A Polymorphism and Therapeutic Effectiveness of Lidocaine Local Anesthetic Injection in Subjects with Diabetic Neuropathy Pain}, journal = {Pharmacognosy Journal}, volume = {16}, year = {2024}, month = {December 2024}, pages = {1259-1263}, type = {Original Article}, chapter = {1259}, abstract = {

Background: Diabetic neuropathy pain (DNP) is one of the complications experienced by more than half of the diabetic population. Treatment using lidocaine injection is one of the effective ways to manage pain in patients with DNP. Pain therapy using lidocaine locally targets the SCN9A and SCN10A genes, which encode the sodium receptors Nav1.7 and Nav1.8. The effect of lidocaine inhibits these sodium channels to reduce pain transmission. Purpose: This study aims to analyze the effect of polymorphism of genes encoding Nav1.7 and Nav1.8 on the effectiveness of lidocaine local injection therapy in patients with DNP. Methods: This study was an analytic observational study with a cross-sectional approach. A total of 63 people with DNP were genotyped for the SCN9A rs 6746030 gene and the SCN10A rs12632942 gene using Real-Time PCR/qPCR and DNA sequencing. Result: The results showed that 91.2\% and 70.6\% of the population who experienced decreased pain had the GA mutant allele in the SCN9A rs6746030 gene and the AG mutant allele in the SCN10A rs12632942 gene. The results showed a significant association of Nav1.7 and Nav1.8 gene polymorphisms with the effectiveness of lidocaine local anesthetic injection therapy in diabetic neuropathy pain patients (p \< 0.05). Conclusion: This study shows that there was an association between Nav1.7 and Nav1.8 gene polymorphisms and the effectiveness of lidocaine local anesthetic injection therapy in patients with DNP. Lidocaine injection therapy that targets the Nav1.7 and Nav1.8 sodium channels involving the SCN9A and SCN10A genes can be a therapeutic alternative for patients with DNP.

}, keywords = {Diabetes, Diabetic neuropathy pain, Nav1.7, Nav1.8, Polymorphism}, doi = {10.5530/pj.2024.16.204}, author = {I Made Subhawa Harsa and Andiani and Sulistiawati and Lilik Herawati and Hanik Badriyah Hidayati and Kuntaman} }